ALLISON HERRON: Open Payments
NPI 1720563612 · BIG STONE GAP, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$747 in 46 payments from 13 companies in 2025. Trend: 2023 $546 · 2024 $601 · 2025 $747
Food & beverage: $747
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $206 |
| ABBVIE INC. | 13 | $164 |
| AstraZeneca Pharmaceuticals LP | 5 | $94 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $67 |
| Axsome Therapeutics, Inc. | 3 | $57 |
| Novo Nordisk Inc | 3 | $47 |
| Janssen Pharmaceuticals, Inc | 1 | $24 |
| Ardelyx, Inc. | 1 | $20 |
| Sumitomo Pharma America, Inc. | 1 | $14 |
| E.R. Squibb & Sons, L.L.C. | 1 | $14 |
Products named: CAPLYTA, XIFAXAN, FARXIGA, Auvelity, VRAYLAR, QULIPTA, UBRELVY, Rybelsus.
Industry payments across VA — which companies pay providers there.
